Rejuvel Bio-sciences, Inc. Net Income per Employee (NUUU), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Rejuvel Bio-sciences, Inc.  (NUUU)
 

Rejuvel Bio-sciences Net Income per Employee

NUUU's Quarterly Results, Trends, Rankings, Statistics
Rejuvel Bio-sciences, Inc. recorded a cumulative net loss of $-1 million during 12 month ending in the third quarter 2015.
The Consumer Non Cyclical sector has seen employees of 46 other companies achieving higher income per employee. While Rejuvel Bio-sciences's total ranking has deteriorated compared to the previous quarter from 0 to 3675.


What is Income per Employee Ratio?






NUUU Net Income per Employee (Sep 30 2015)
III. Quarter
(Jun 30 2015)
II. Quarter
(Mar 31 2015)
I. Quarter
(Dec 31 2014)
IV. Quarter
(Sep 30 2014)
III. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ -1,052,017 -549,306 1,790,108 -352,865 -734,743
NUUU's Total Ranking # 3675 # 0 # 0 # 0 #
Seq. Net Income Change - - - -15.36 % -89.76 %


NUUU Net Income per Employee Company Ranking
Within: No.
Food Processing Industry # 47
Consumer Non Cyclical Sector # 149
Overall Market # 3675

Net Income per Employee Statistics
High Average Low
$ 1,406,906 $ -790,443 $ -2,914,885
(Jun 30 2015)   (Mar 31 2014)







Companies with similar Income per Employee for 12 month ending Sep 30 2015, within Consumer Non Cyclical Sector Income per Employee Income 12 month ending Sep 30 2015Number of Employees Sep 30 2015


Date modified: 2026-09-12T06:20:11+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.